NCT00351117View on ClinicalTrials.gov

St. John's Wort in the Treatment of Raynaud's Phenomenon

PHASE3CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

March 31, 2007

Primary Completion Date

August 31, 2008

Study Completion Date

August 31, 2008

Conditions
Raynaud's Disease
Interventions
DRUG

St. John's Wort

SJW in capsule form 300 mg PO TID

DRUG

Lactose

lactose in gelatin capsule that same as St. John's wort

Trial Locations (1)

N6A 4V2

Rheumatology Clinic, St. Joseph's Health Care, London

All Listed Sponsors
lead

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

OTHER

NCT00351117 - St. John's Wort in the Treatment of Raynaud's Phenomenon | Biotech Hunter | Biotech Hunter